Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy
Kim, S-M, Kim, H, Yun, M R, Kang, H N, Pyo, K-H, Park, H J, Lee, J M, Choi, H M, Ellinghaus, P, Ocker, M, Paik, S, Kim, H R, Cho, B CVolume:
5
Language:
english
Journal:
Oncogenesis
DOI:
10.1038/oncsis.2016.48
Date:
July, 2016
File:
PDF, 2.64 MB
english, 2016